Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Elemental iodine or iodine compound
Reexamination Certificate
2011-06-28
2011-06-28
Witz, Jean (Department: 4131)
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Elemental iodine or iodine compound
C424S133100, C514S167000, C514S007800, C514S410000, C514S681000, C514S224800, C514S411000, C514S454000
Reexamination Certificate
active
07968127
ABSTRACT:
A formulation or preparation for treating and preventing arterial and venous thrombi is provided. This preparation includes a non-metal containing photodynamic dye and a fat soluble vitamin. A method of administration for treatment and prophylaxis of arterial and venous thrombi is also provided. This method includes steps of: combining a non-metal containing photodynamic dye and a fat soluble vitamin; combining the non-metal containing photodynamic dye and fat soluble vitamin with a sodium solution; and administering the combination of non-metal containing photodynamic dye, fat soluble vitamin, and sodium solution as an intravenous drip.
REFERENCES:
patent: 5789433 (1998-08-01), Chan et al.
patent: 6096776 (2000-08-01), Chan et al.
patent: 6235767 (2001-05-01), Kelly et al.
patent: 6790463 (2004-09-01), Hofmann et al.
patent: 2008/0069814 (2008-03-01), Curd et al.
Michael Nesheim, PhD; “Thrombin and Fibrinolysis” (Chest.2003;124:33S-39S.) © 2003 American College of Chest Physicians.
Bajzar L, Morser J, Nesheim J; TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex.
Hofmann, Nadalo, Winslow; A Novel Intracellular Peroxidation-Inducing Drug Therapy for the Treatment of Post Cardiac Procedure Angina Pectoris and Cardiac Insufficiency.
Mansfield, Brown, McEwan; Photodynamic therapy: shedding light on restenosis; Heart 2001;86:612-618.
Su, Frederick; Photodynamic therapy: a maturing medical technology; Feb. 2000; No. 194.
Kereiakes; Coronary Artery Restenosis: Vision to the Future; Reviews in Cardiovascular Medicine; vol. 5, Suppl. 2 2004.
Mallat and Tedgui; Current Perspective on the Role of Apoptosis in Artherothrombotic Disease; Circulation Research; 2001;88:998-1003.
Kereiakes; Coronary Small-Vessel Stenting in the Era of Drug Elution; Reviews in Cardiovascular Medicine; S34 vol. 5 Suppl. 2 2004.
McClean; Stent Design: Implications for Restenosis; Reviews in Cardiovascular Medicine; S16 vol. 3 Suppl. 5 2002.
Kereiakes; Thrombosis and Drug-Eluting Stents: A Critical Appraisal; Reviews in Cardiovascular Medicine; vol. 5 No. 1 2004.
Sluijter, Smeets, Velema, Pasterkamp, De Kleijn; Increased collagen turnover is only partly associated with collagen fiber deposition in the arterial response to injury; Cardiovascular Research 61 (2004) 186-195.
Chandrasekharan, Simmons; The cyclooxygenases; Genome Biology 2004, 5:241.
Campbell; Drug-eluting Stents: Role of Stent Design, Delivery Vehicle, and Drug Selection; Reviews in Cardiovascular Medicine, S10 vol. 3 Suppl. 5 2002.
Editorial; Glyoxylide; htt://www.williamfkoch.com/texts/editorial/F.JAMERASSOC.htm(1 of 43)Jan. 5, 2005.
Costa, Lansky, Mintz, Mehran, Tsuchiya, Negoita, Gilutz, Nikolsky, Fahy, Pop, Cristea, Carlier, Dangas, Stone, Leon, Muller, Techen, and Grube; Angiographic Results of the First Human Experience with Everolimus-Eluting Stents for the Treatment of Coronary Lesions (the Future I Trial).
Rocnik, Chan, Pickering; Evidence for a Role of Collagen Synthesis in Arterial Smooth Muscle Cell Migration; J. Clin. Invest. vol. 101, No. 9, May 1998, 1889-1898.
Maruyama, Sekimoto, Ishibashi, Inouye, Oshima, Yamaguchi, and Abe; Suppression of neutrophil accumulation in mice by cutaneous application of geranium essential oil; Journal of Inflammation 2005, 2:1 doi:10.1186/1476-9255-2-1.
Spectroscopic Methods in Structure Determination.
Hulten, Holmstrom, and Soussi; Harmful Singlet Oxygen can be helpful; Free Radical Biology & Medicine, vol. 27, Nos. 11/12 pp, 1203-1207, 1999.
Nakamura, Lee, and Yeung; Identification and Treatment of Vulnerable Plaque; Coronary Artery Restenosis; S22 vol. 5 Suppl. 2 2004 Reviews in Cardiovascular Medicine.
Kereiakes, The Emperor's Clothes —In Search of the Vulnerable Plaque; Circulation —American Heart AssociationLearn and Life; Circulation. 2003; 107:2076.
Watson (reviewed); Shimada; Atherosclerosis; Reviews in Cardiovascular Medicine, vol. 5 No. 1 2004.
Holmes, Jr.; In-Stent Restenosis; Reviews in Cardiovascular Medicine, vol. 2 No. 3 2001.
Brinker; What Every Cardiologist Should Know About Intravascular Contrast; Reviews in Cardiovascular Medicine, vol. 4 Suppl. 5 2003.
Odinokov, Spivak, Emelyanova, Mallyabaeva, Nazarova, Dzhemilev; Synthesis of α-tocopherol (vitamin E), vitamin K1-chromanol, and their analogs in the presence of aluminosilicate catalysts Tseokar-10 and Pentasil; ARKIVOC 2003(xiii) 101-118; ISSN 1424-6376.
Niki; Antioxidants and atherosclerosis; Biochemical Society Transactions (2004) vol. 32, part 1.
Irani; Oxidant Signaling in Vascular Cell Growth, Death, and Survival; 2000 American heart Association, Inc.
Burner, Krapfenbauer, Furtmuller, Regelsberger, Obinger; Oxidation of hydroquinone, 2,3-dimethylhydroquinone and 2,3,5-trimethylhydroquinone by human myeloperoxidase; Redox Report, vol. 5, No. 4, 2000.
Schwartz and Henry; Pathophysiology of Coronary Artery Restenosis; Reviews in Cardiovascular Medicine, vol. 3 Suppl. 5 2002.
Overhaus, Heckenkamp, Kossodo, Leszczynski, and Lamuraglia; Photodynamic Therapy Generates a Matrix Barrier to Invasive Vascular Cell Migration; 2000 American Heart Association, Inc.
Kereiakes, Szyniszewski, Wahr, Herrmann, Simon, Rogers, Kramer, Shear, Yeung, Shunk, Chou, Popma, Fitzgerald, Carroll, Forer, and Adelman; Phase I Drug and Light Dose-Escalation Trial of Motexafin Lutetium and Far Red Light Activation (Phototherapy) in Subjects With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention and Stent Deployment; DOI: 10.1161/01.CIR.0000087602.91755.19.
Kipshidze and Sahota; Photoangioplasty Recount: Clear Punch or Dimpled Chad?
Rockson, Lorenz, Cheong, Woodburn; Photoangioplasty-An Emerging Clinical Cardiovascular Role for Photodynamic Therapy.
Wang, Gao, Zhou, and Selke; Nanomaterials and singlet oxygen photosensitizers: potential applications in photodynamic therapy; J. Mater. Chem., 2004, 14(4), 487-493 DOI: 10.1039/b311429e.
Mansfield, Bown, McEwan; Photodynamic therapy: shedding light on restenosis; Review —Heart 2001;86:612-618.
Shallenberger, 13 Major Effects of Ozone on the Human Body.
Barnes & Thornburg LLP
Falkowitz Anna
Witz Jean
LandOfFree
Reverse vitamin K effect via photodynamic oxidation targeted... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Reverse vitamin K effect via photodynamic oxidation targeted..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reverse vitamin K effect via photodynamic oxidation targeted... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2703177